Reversed-phase high-performance liquid chromatographic determination of the new antitumor agent cyclopentenyl cytosine in biological fluidsHEGEDUS, L; FORD, H. JR; HARTMAN, N. R et al.Journal of chromatography. B, Biomedical sciences and applications. 1997, Vol 692, Num 1, pp 169-179, issn 1387-2273Article

Potent activity of 2'-β-fluoro-2'-3'-dideoxyadenosine against human immunodeficiency virus type 1 infection in hu-PBL-SCID miceRUXRUNGTHAM, K; BOONE, E; FORD, H. JR et al.Antimicrobial agents and chemotherapy. 1996, Vol 40, Num 10, pp 2369-2374, issn 0066-4804Article

Measurement of cyclopentenyl cytosine 5-triphosphate in vitro and in vivo by multidimensional high-performance liquid chromatographyRIAD AGBARIA; FORD, H. JR; KELLEY, J. A et al.Analytical biochemistry. 1993, Vol 213, Num 1, pp 90-96, issn 0003-2697Article

Phase I clinical trial of continuous infusion cyclopentenyl cytosinePOLITI, P. M; FUMING XIE; ARBUCK, S. F et al.Cancer chemotherapy and pharmacology. 1995, Vol 36, Num 6, pp 513-523, issn 0344-5704Article

Chemistry and anti-HIV activity of 2'-β-fluoro-2',3'-dideoxyguanosineFORD, H. JR; DRISCOLL, J. S; SIDDIQUI, M et al.Nucleosides & nucleotides. 1994, Vol 13, Num 1-3, pp 213-234, issn 0732-8311Article

In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatineKAGEYAMA, S; MIMOTO, T; BRODER, S et al.Antimicrobial agents and chemotherapy. 1993, Vol 37, Num 4, pp 810-817, issn 0066-4804Article

Potential anti-AIDS drugs. Lipophilic, adenosine deaminase-activated prodrugsBARCHI, J. J; MARQUEZ, V. E; DRISCOLL, J. S et al.Journal of medicinal chemistry (Print). 1991, Vol 34, Num 5, pp 1647-1655, issn 0022-2623, 9 p.Article

Phase I and pharmacokinetic study of arabinofuranosyl-5-azacytosine (fazarabine, NSC 281272)SURBONE, A; FORD, H. JR; KELLEY, J. A et al.Cancer research (Baltimore). 1990, Vol 50, Num 4, pp 1220-1225, issn 0008-5472Article

Comparison of the DNA incorporation in human MOLT-4 cells of two 2'-β-fluoronucleosides, 2'-β-fluoro-2',3'-dideoxyadenosine and fialuridineAHLUWALIA, G. S; DRISCOLL, J. S; FORD, H. JR et al.Journal of pharmaceutical sciences. 1996, Vol 85, Num 4, pp 454-455, issn 0022-3549Article

Lipophilic, acid-stable, adenosine deaminase-activated anti-HIV prodrugs for central nervous system delivery. III. 6-amino prodrugs of 2'-β-fluoro-2',3'-dideoxyinosineDRISCOLL, J. S; SIDDIQUI, M. A; FORD, H. JR et al.Journal of medicinal chemistry (Print). 1996, Vol 39, Num 8, pp 1619-1625, issn 0022-2623Article

Lipophilic, acid-stable, adenosine deaminase-activated anti-HIV prodrugs for central nervous system delivery. II: 6-halo and 6-alkoxy prodrugs of 2'-β-fluoro-2',3'-dideoxyinosineFORD, H. JR; SIDDIQUI, M. A; DRISCOLL, J. S et al.Journal of medicinal chemistry (Print). 1995, Vol 38, Num 7, pp 1189-1195, issn 0022-2623Article

Reversal by cytidine of cyclopentenyl cytosine-induced toxicity in mice without compromise of antitumor activityFORD, H. JR; DRISCOLL, J. S; COONEY, D. A et al.Biochemical pharmacology. 1995, Vol 49, Num 2, pp 173-180, issn 0006-2952Article

Site of action of two novel pyrimidine biosynthesis inhibitors accurately predicted by the compare programCLEAVELAND, E. S; MONKS, A; VAIGRO-WOLFF, A et al.Biochemical pharmacology. 1995, Vol 49, Num 7, pp 947-954, issn 0006-2952Article

A rapid microscale method for the determination of partition coefficients by HPLCFORD, H. JR; MERSKI, C. L; KELLEY, J. A et al.Journal of liquid chromatography. 1991, Vol 14, Num 18, pp 3365-3386, issn 0148-3919Article

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancerWILDNER, O; MORRIS, J. C; VAHANIAN, N. N et al.Gene therapy (Basingstoke). 1999, Vol 6, Num 1, pp 57-62, issn 0969-7128Article

4'-O-[2-(2-fluoromalonyl)]-L-tyrosine : a phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptidesBURKE, T. R; BIN YE; AKAMATSU, M et al.Journal of medicinal chemistry (Print). 1996, Vol 39, Num 5, pp 1021-1027, issn 0022-2623Article

A general method for the preparation of benzylic α,α-difluorophosphonic acids ; non-hydrolyzable mimetics of phosphotyrosineSMYTH, M. S; FORD, H. JR; BURKE, T. R et al.Tetrahedron letters. 1992, Vol 33, Num 29, pp 4137-4140, issn 0040-4039Article

Cellular pharmacology of cyclopentenyl cytosine in mold-4 lymphoblastsFORD, H. JR; COONEY, D. A; AHLUWALIA, G. S et al.Cancer research (Baltimore). 1991, Vol 51, Num 14, pp 3733-3740, issn 0008-5472, 8 p.Article

Escherichia coli mediated biosynthesis and in vitro anti-HIV activity of lipophilic 6-halo-2',3'-dideoxypurine nucleosidesMURAKAMI, K; SHIRASAKA, T; YOSHIOKA, H et al.Journal of medicinal chemistry (Print). 1991, Vol 34, Num 5, pp 1606-1612, issn 0022-2623, 7 p.Article

Reverse phase HPLC determination and murine pharmacokinetics of arabinosyl-5-azacytosineHEIDEMAN, R. L; ROTH, J. S; FORD, H. JR et al.Journal of liquid chromatography. 1989, Vol 12, Num 9, pp 1613-1633, issn 0148-3919, 21 p.Article